Centessa Pharmaceuticals plc Competitors
| Symbol | Company | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
|---|---|---|---|---|---|---|
 CCCC
|
C4 Therapeutics, Inc. | $6.10 | $320.64 M | -1.97 | 145 | $20.76 M |
 CGEM
|
Cullinan Oncology, Inc. | $15.98 | $1.29 B | -7.16 | 85 | $0 |
 CRNX
|
Crinetics Pharmaceuticals, Inc. | $57.88 | $3.53 B | -11.86 | 290 | $4.01 M |
 DSGN
|
Design Therapeutics, Inc. | $5.55 | $217.51 M | -3.7 | 57 | $0 |
 ERAS
|
Erasca, Inc. | $2.95 | $647.94 M | -2.83 | 126 | $0 |
 EWTX
|
Edgewise Therapeutics, Inc. | $35.91 | $1.65 B | -11.47 | 97 | $0 |
 GLUE
|
Monte Rosa Therapeutics, Inc. | $9.36 | $243.38 M | -1.59 | 129 | $0 |
 GNFT
|
Genfit S.A. | $5.79 | $269.95 M | -8.62 | 169 | $28.57 M |
 GRCL
|
Gracell Biotechnologies Inc. | $10.25 | $989.87 M | -10.57 | 314 | $0 |
 HLVX
|
HilleVax, Inc. | $1.89 | $673.22 M | -4.1 | 90 | $0 |
|
IPSC
|
Century Therapeutics, Inc. | $1.33 | $244.54 M | -1.32 | 152 | $2.24 M |
|
IRON
|
Disc Medicine, Inc. | $64.76 | $967.11 M | -11.82 | 78 | $0 |
 LRMR
|
Larimar Therapeutics, Inc. | $7.36 | $611.84 M | -9.99 | 42 | $0 |
|
MLYS
|
Mineralys Therapeutics, Inc. | $13.49 | $652.38 M | -6.03 | 28 | $0 |
|
NAMSW
|
NewAmsterdam Pharma Company N.V. | $10.00 | $1.74 B | 0 | 57 | $12.76 M |
 NUVL
|
Nuvalent, Inc. | $91.90 | $5.11 B | -32.72 | 115 | $0 |
 OPT
|
Opthea Limited | $4.19 | $214.34 M | -1.04 | 33 | $125,122 |
|
STRO
|
Sutro Biopharma, Inc. | $3.84 | $303.46 M | -1.97 | 304 | $153.73 M |
|
TARS
|
Tarsus Pharmaceuticals, Inc. | $45.66 | $1.22 B | -6.78 | 244 | $17.45 M |
 THRX
|
Theseus Pharmaceuticals, Inc. | $4.07 | $181.50 M | -3.03 | 38 | $0 |
 TRDA
|
Entrada Therapeutics, Inc. | $18.62 | $531.37 M | 22.81 | 168 | $129.01 M |